{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:07:19Z","timestamp":1790996839973,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203528, 82473001, 82272891"],"award-info":[{"award-number":["82203528, 82473001, 82272891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s13402-024-01027-4","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T08:25:39Z","timestamp":1734683139000},"page":"2099-2112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic insights into tumor lymph node metastasis in melanoma"],"prefix":"10.1007","volume":"47","author":[{"given":"Jiayi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangying","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"10151","key":"1027_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"D. Schadendorf, A.C.J. van Akkooi, C. Berking et al., Melanoma Lancet. 392(10151), 971\u2013984 (2018)","journal-title":"Melanoma Lancet"},{"issue":"1","key":"1027_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"R.L. Siegel, K.D. Miller, N.S. Wagle, A. Jemal, Cancer statistics, 2023. CA: Cancer J. Clin. 73(1), 17\u201348 (2023)","journal-title":"J. Clin."},{"key":"1027_CR3","doi-asserted-by":"publisher","first-page":"1061982","DOI":"10.3389\/fcell.2022.1061982","volume":"10","author":"A Benito-Mart\u00edn","year":"2023","unstructured":"A. Benito-Mart\u00edn, M.G. Jasiulionis, S. Garc\u00eda-Silva, Extracellular vesicles and melanoma: new perspectives on tumor microenvironment and metastasis. Front. Cell. Dev. Biol. 10, 1061982 (2023)","journal-title":"Front. Cell. Dev. Biol."},{"key":"1027_CR4","first-page":"1","volume":"00","author":"JY Song","year":"2023","unstructured":"J.Y. Song, Y.J. Ryu, H.K. Lee et al., Risk factors for sentinel lymph node metastasis in Korean acral and non-acral melanoma patients. Pigment Cell. Melanoma Res. 00, 1\u201311 (2023)","journal-title":"Pigment Cell. Melanoma Res."},{"key":"1027_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1200\/PO.19.00206","volume":"4","author":"D Bellomo","year":"2020","unstructured":"D. Bellomo, S.M. Arias-Mejias, C. Ramana et al., Model combining Tumor Molecular and clinicopathologic risk factors predicts Sentinel Lymph Node Metastasis in primary cutaneous melanoma. JCO Precis Oncol. 4, 319\u2013334 (2020)","journal-title":"JCO Precis Oncol."},{"issue":"7","key":"1027_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"D.L. Morton, J.F. Thompson, A.J. Cochran et al., Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl. J. Med. 370(7), 599\u2013609 (2014)","journal-title":"N Engl. J. Med."},{"issue":"6","key":"1027_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"J.E. Gershenwald, R.A. Scolyer, K.R. Hess et al., Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J. Clin. 67(6), 472\u2013492 (2017)","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"1027_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41590-022-01141-1","volume":"23","author":"AC Huang","year":"2022","unstructured":"A.C. Huang, R. Zappasodi, A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. Nat. Immunol. 23(5), 660\u2013670 (2022)","journal-title":"Nat. Immunol."},{"key":"1027_CR9","doi-asserted-by":"publisher","first-page":"101217","DOI":"10.1016\/j.molmet.2021.101217","volume":"48","author":"P Malvi","year":"2021","unstructured":"P. Malvi, R. Janostiak, A. Nagarajan, X. Zhang, N. Wajapeyee, N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production. Mol. Metab. 48, 101217 (2021)","journal-title":"Mol. Metab."},{"issue":"17","key":"1027_CR10","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-18-1550","volume":"25","author":"SA Weiss","year":"2019","unstructured":"S.A. Weiss, J.D. Wolchok, M. Sznol, Immunotherapy of Melanoma: facts and hopes. Clin. Cancer Res. 25(17), 5191\u20135201 (2019)","journal-title":"Clin. Cancer Res."},{"key":"1027_CR11","doi-asserted-by":"crossref","unstructured":"L. Yang, D. Wang, H. Jia et al., Tumor-specific peroxynitrite overproduction disrupts metabolic homeostasis for sensitizing melanoma immunotherapy. Adv. Mater. 35(29), e2301455 (2023)","DOI":"10.1002\/adma.202301455"},{"issue":"12","key":"1027_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"K. DePeaux, G.M. Delgoffe, Metabolic barriers to cancer immunotherapy. Nat. Rev. Immunol. 21(12), 785\u2013797 (2021)","journal-title":"Nat. Rev. Immunol."},{"issue":"7851","key":"1027_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-021-03326-4","volume":"591","author":"R Zappasodi","year":"2021","unstructured":"R. Zappasodi, I. Serganova, I.J. Cohen et al., CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours. Nature. 591(7851), 652\u2013658 (2021)","journal-title":"Nature"},{"issue":"5","key":"1027_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"H. Peinado, H. Zhang, I.R. Matei et al., Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer. 17(5), 302\u2013317 (2017)","journal-title":"Nat. Rev. Cancer"},{"key":"1027_CR15","doi-asserted-by":"publisher","first-page":"101975","DOI":"10.1016\/j.ctrv.2020.101975","volume":"85","author":"R Gowda","year":"2020","unstructured":"R. Gowda, B.M. Robertson, S. Iyer et al., The role of exosomes in metastasis and progression of melanoma. Cancer Treat. Rev. 85, 101975 (2020)","journal-title":"Cancer Treat. Rev."},{"key":"1027_CR16","doi-asserted-by":"publisher","first-page":"1002551","DOI":"10.3389\/fimmu.2022.1002551","volume":"13","author":"LC Dieterich","year":"2022","unstructured":"L.C. Dieterich, Mechanisms of extracellular vesicle-mediated immune evasion in melanoma. Front. Immunol. 13, 1002551 (2022)","journal-title":"Front. Immunol."},{"issue":"6282","key":"1027_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.aaf1328","volume":"352","author":"F Pucci","year":"2016","unstructured":"F. Pucci, C. Garris, C.P. Lai et al., SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions. Science. 352(6282), 242\u2013246 (2016)","journal-title":"Science"},{"issue":"4","key":"1027_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1152\/physrev.00039.2021","volume":"102","author":"LC Dieterich","year":"2022","unstructured":"L.C. Dieterich, C. Tacconi, L. Ducoli, Detmar. Lymphatic vessels in cancer. Physiol. Rev. 102(4), 1837\u20131879 (2022)","journal-title":"Physiol. Rev."},{"issue":"9","key":"1027_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2023.07.002","volume":"44","author":"S Suman","year":"2023","unstructured":"S. Suman, S.N. Markovic, Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis. Trends Immunol. 44(9), 724\u2013743 (2023)","journal-title":"Trends Immunol."},{"key":"1027_CR20","doi-asserted-by":"crossref","unstructured":"N. Leary, S. Walser, Y. He et al., Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes. J. Extracell. Vesicles 11(2), e12197 (2022)","DOI":"10.1002\/jev2.12197"},{"issue":"1","key":"1027_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10585-021-10120-z","volume":"39","author":"SP Leong","year":"2022","unstructured":"S.P. Leong, K. Naxerova, L. Keller, K. Pantel, M. Witte, Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin. Exp. Metastasis. 39(1), 159\u2013179 (2022)","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"1027_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/modpathol.2010.227","volume":"24","author":"AS Mansfield","year":"2011","unstructured":"A.S. Mansfield, S.G. Holtan, T.E. Grotz et al., Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod. Pathol. 24(4), 487\u2013494 (2011)","journal-title":"Mod. Pathol."},{"issue":"9","key":"1027_CR23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ni.3492","volume":"17","author":"A Riedel","year":"2016","unstructured":"A. Riedel, D. Shorthouse, L. Haas, B.A. Hall, J. Shields, Tumor-induced stromal reprogramming drives lymph node transformation. Nat. Immunol. 17(9), 1118\u20131127 (2016)","journal-title":"Nat. Immunol."},{"issue":"12","key":"1027_CR24","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/j.jid.2017.07.006","volume":"137","author":"M Gassenmaier","year":"2017","unstructured":"M. Gassenmaier, T.K. Eigentler, U. Keim et al., Serial or parallel metastasis of cutaneous melanoma? A study of the German Central Malignant Melanoma Registry. J. Invest. Dermatol. 137(12), 2570\u20132577 (2017)","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"1027_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1001\/jamadermatol.2019.0069","volume":"155","author":"L Calomarde-Rees","year":"2019","unstructured":"L. Calomarde-Rees, R. Garc\u00eda-Calatayud, C. Requena Caballero et al., Risk factors for lymphatic and hematogenous dissemination in patients with stages I to II cutaneous melanoma. JAMA Dermatol. 155(6), 679 (2019)","journal-title":"JAMA Dermatol."},{"issue":"7823","key":"1027_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"J.M. Ubellacker, A. Tasdogan, V. Ramesh et al., Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 585(7823), 113\u2013118 (2020)","journal-title":"Nature"},{"key":"1027_CR27","doi-asserted-by":"publisher","first-page":"101753","DOI":"10.1016\/j.redox.2020.101753","volume":"37","author":"LR Arslanbaeva","year":"2020","unstructured":"L.R. Arslanbaeva, M.M. Santoro, Adaptive redox homeostasis in cutaneous melanoma. Redox Biol. 37, 101753 (2020)","journal-title":"Redox Biol."},{"issue":"4","key":"1027_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/antiox11040612","volume":"11","author":"M Emanuelli","year":"2022","unstructured":"M. Emanuelli, D. Sartini, E. Molinelli et al., The double-edged Sword of oxidative stress in skin damage and melanoma: from physiopathology to Therapeutical approaches. Antioxid. (Basel). 11(4), 612 (2022)","journal-title":"Antioxid. (Basel)"},{"key":"1027_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.abb.2014.04.007","volume":"563","author":"F Liu-Smith","year":"2014","unstructured":"F. Liu-Smith, R. Dellinger, F.L. Meyskens, Updates of reactive oxygen species in melanoma etiology and progression. Arch. Biochem. Biophys. 563, 51\u201355 (2014)","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"1027_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1074\/jbc.M507471200","volume":"281","author":"M Benlloch","year":"2006","unstructured":"M. Benlloch, S. Mena, P. Ferrer et al., Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched Diet facilitate elimination of highly resistant B16 melanoma cells by Tumor Necrosis Factor-\u03b1 and chemotherapy. J. Biol. Chem. 281(1), 69\u201379 (2006)","journal-title":"J. Biol. Chem."},{"issue":"12","key":"1027_CR31","doi-asserted-by":"publisher","first-page":"9997","DOI":"10.1002\/jcp.29814","volume":"235","author":"Y Yu","year":"2020","unstructured":"Y. Yu, D. Ladeiras, Y. Xiong et al., Arginase-II promotes melanoma migration and adhesion through enhancing hydrogen peroxide production and STAT3 signaling. J. Cell. Physiol. 235(12), 9997\u201310011 (2020)","journal-title":"J. Cell. Physiol."},{"issue":"7620","key":"1027_CR32","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature19347","volume":"537","author":"C Luo","year":"2016","unstructured":"C. Luo, J. Lim, Y. Lee et al., A PGC1\u03b1-mediated transcriptional axis suppresses melanoma metastasis. Nature. 537(7620), 422\u2013426 (2016)","journal-title":"Nature"},{"issue":"44","key":"1027_CR33","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1038\/s41388-020-01477-8","volume":"39","author":"C Jessen","year":"2020","unstructured":"C. Jessen, J.K.C. Kre\u00df, A. Baluapuri et al., The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression. Oncogene. 39(44), 6841\u20136855 (2020)","journal-title":"Oncogene"},{"issue":"6","key":"1027_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO;2-3","volume":"67","author":"S De Flora","year":"1996","unstructured":"S. De Flora, F. D\u2019Agostini, L. Masiello, D. Giunciuglio, A. Albini, Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int. J. Cancer. 67(6), 842\u2013848 (1996)","journal-title":"Int. J. Cancer"},{"issue":"9","key":"1027_CR35","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1158\/2326-6066.CIR-16-0382","volume":"5","author":"E Aydin","year":"2017","unstructured":"E. Aydin, J. Johansson, F.H. Nazir, K. Hellstrand, A. Martner, Role of NOX2-Derived reactive oxygen species in NK cell\u2013mediated control of murine Melanoma Metastasis. Cancer Immunol. Res. 5(9), 804\u2013811 (2017)","journal-title":"Cancer Immunol. Res."},{"key":"1027_CR36","doi-asserted-by":"crossref","unstructured":"K. Le Gal, M.X. Ibrahim, C. Wiel et al., Antioxidants can increase melanoma metastasis in mice. Sci. Transl Med. 7(308), 308re8-308re8 (2015)","DOI":"10.1126\/scitranslmed.aad3740"},{"key":"1027_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcdb.2019.05.001","volume":"98","author":"V Audrito","year":"2020","unstructured":"V. Audrito, A. Manag\u00f2, F. Gaudino, S. Deaglio, Targeting metabolic reprogramming in metastatic melanoma: the key role of nicotinamide phosphoribosyltransferase (NAMPT). Semin Cell. Dev. Biol. 98, 192\u2013201 (2020)","journal-title":"Semin Cell. Dev. Biol."},{"issue":"9","key":"1027_CR38","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"J.R. Doherty, J.L. Cleveland, Targeting lactate metabolism for cancer therapeutics. J. Clin. Invest. 123(9), 3685\u20133692 (2013)","journal-title":"J. Clin. Invest."},{"issue":"3","key":"1027_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/cancers12030767","volume":"12","author":"Y Kim","year":"2020","unstructured":"Y. Kim, J. Gil, I. Pla et al., Protein expression in metastatic melanoma and the link to Disease Presentation in a range of Tumor phenotypes. Cancers (Basel). 12(3), 767 (2020)","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1027_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pcmr.12661","volume":"31","author":"GM Fischer","year":"2018","unstructured":"G.M. Fischer, Y.N. Vashisht Gopal, J.L. McQuade et al., Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and therapeutic implications. Pigment Cell. Melanoma Res. 31(1), 11\u201330 (2018)","journal-title":"Pigment Cell. Melanoma Res."},{"issue":"11","key":"1027_CR41","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/15384101.2016.1175258","volume":"15","author":"C Pinheiro","year":"2016","unstructured":"C. Pinheiro, V. Miranda-Gon\u00e7alves, A. Longatto-Filho et al., The metabolic microenvironment of melanomas: prognostic value of MCT1 and MCT4. Cell. Cycle. 15(11), 1462\u20131470 (2016)","journal-title":"Cell. Cycle"},{"issue":"1","key":"1027_CR42","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1038\/s41467-020-17756-7","volume":"11","author":"H Wu","year":"2020","unstructured":"H. Wu, V. Estrella, M. Beatty et al., T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nat. Commun. 11(1), 4113 (2020)","journal-title":"Nat. Commun."},{"issue":"4","key":"1027_CR43","doi-asserted-by":"publisher","first-page":"584","DOI":"10.18632\/oncotarget.965","volume":"4","author":"A Hall","year":"2013","unstructured":"A. Hall, K.D. Meyle, M.K. Lange et al., Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene. Oncotarget. 4(4), 584\u2013599 (2013)","journal-title":"Oncotarget"},{"issue":"7","key":"1027_CR44","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1158\/0008-5472.CAN-06-3312","volume":"67","author":"SM Kumar","year":"2007","unstructured":"S.M. Kumar, H. Yu, R. Edwards et al., Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res. 67(7), 3177\u20133184 (2007)","journal-title":"Cancer Res."},{"issue":"3","key":"1027_CR45","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jcp.20166","volume":"202","author":"ML Macheda","year":"2005","unstructured":"M.L. Macheda, S. Rogers, J.D. Best, Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202(3), 654\u2013662 (2005)","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"1027_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1476-4598-11-76","volume":"11","author":"J Ho","year":"2012","unstructured":"J. Ho, M.B. de Moura, Y. Lin et al., Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol. Cancer. 11(1), 76 (2012)","journal-title":"Mol. Cancer"},{"issue":"51","key":"1027_CR47","doi-asserted-by":"publisher","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","volume":"271","author":"GL Semenza","year":"1996","unstructured":"G.L. Semenza, B.H. Jiang, S.W. Leung et al., Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271(51), 32529\u201332537 (1996)","journal-title":"J. Biol. Chem."},{"issue":"1","key":"1027_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CMR.0000000000000520","volume":"29","author":"F Petrelli","year":"2019","unstructured":"F. Petrelli, R. Ardito, B. Merelli et al., Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis. Melanoma Res. 29(1), 1\u201312 (2019)","journal-title":"Melanoma Res."},{"issue":"3","key":"1027_CR49","first-page":"597","volume":"159","author":"ZI Nowecki","year":"2008","unstructured":"Z.I. Nowecki, P. Rutkowski, J. Kulik, J.A. Siedlecki, W. Ruka, Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Br. J. Dermatol. 159(3), 597\u2013605 (2008)","journal-title":"Br. J. Dermatol."},{"issue":"22","key":"1027_CR50","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.3390\/cancers13225810","volume":"13","author":"A Alkaraki","year":"2021","unstructured":"A. Alkaraki, G.A. McArthur, K.E. Sheppard, L.K. Smith, Metabolic plasticity in Melanoma Progression and response to Oncogene targeted therapies. Cancers (Basel). 13(22), 5810 (2021)","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1027_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1034\/j.1600-0560.2003.300104.x","volume":"30","author":"D Innocenzi","year":"2003","unstructured":"D. Innocenzi, P.L. Al\u00f2, A. Balzani et al., Fatty acid synthase expression in melanoma. J. Cutan. Pathol. 30(1), 23\u201328 (2003)","journal-title":"J. Cutan. Pathol."},{"issue":"7635","key":"1027_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"G. Pascual, A. Avgustinova, S. Mejetta et al., Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 541(7635), 41\u201345 (2017)","journal-title":"Nature"},{"issue":"6427","key":"1027_CR53","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aav0173","volume":"363","author":"CK Lee","year":"2019","unstructured":"C.K. Lee, S.H. Jeong, C. Jang et al., Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science. 363(6427), 644\u2013649 (2019)","journal-title":"Science"},{"issue":"2","key":"1027_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/labinvest.2016.125","volume":"97","author":"DC Bastos","year":"2017","unstructured":"D.C. Bastos, J. Paupert, C. Maillard et al., Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model. Lab. Invest. 97(2), 194\u2013206 (2017)","journal-title":"Lab. Invest."},{"issue":"11","key":"1027_CR55","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/ijc.23835","volume":"123","author":"MA Carvalho","year":"2008","unstructured":"M.A. Carvalho, K.G. Zecchin, F. Seguin et al., Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int. J. Cancer. 123(11), 2557\u20132565 (2008)","journal-title":"Int. J. Cancer"},{"issue":"14","key":"1027_CR56","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1158\/0008-5472.CAN-16-0651","volume":"76","author":"I Lazar","year":"2016","unstructured":"I. Lazar, E. Clement, S. Dauvillier et al., Adipocyte exosomes promote Melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and Cancer. Cancer Res. 76(14), 4051\u20134057 (2016)","journal-title":"Cancer Res."},{"issue":"5","key":"1027_CR57","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ajpath.2020.01.012","volume":"190","author":"A Salhi","year":"2020","unstructured":"A. Salhi, A.C. Jordan, I.I. Bochaca et al., Oxidative phosphorylation promotes primary Melanoma Invasion. Am. J. Pathol. 190(5), 1108\u20131117 (2020)","journal-title":"Am. J. Pathol."},{"issue":"6","key":"1027_CR58","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1042\/BJ20150645","volume":"473","author":"MF Rodrigues","year":"2016","unstructured":"M.F. Rodrigues, E. Obre, F.H. de Melo et al., Enhanced OXPHOS, glutaminolysis and \u03b2-oxidation constitute the metastatic phenotype of melanoma cells. Biochem. J. 473(6), 703\u2013715 (2016)","journal-title":"Biochem. J."},{"issue":"1","key":"1027_CR59","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/s12885-021-08385-4","volume":"21","author":"S Salmi","year":"2021","unstructured":"S. Salmi, A. Lin, B. Hirschovits-Gerz et al., The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study. BMC Cancer. 21(1), 641 (2021)","journal-title":"BMC Cancer"},{"issue":"4","key":"1027_CR60","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/CMR.0000000000000751","volume":"31","author":"H He","year":"2021","unstructured":"H. He, B. Qiao, S. Guo et al., Induction of T helper 17 cell response by interleukin-7 in patients with primary cutaneous melanoma. Melanoma Res. 31(4), 328\u2013337 (2021)","journal-title":"Melanoma Res."},{"issue":"7","key":"1027_CR61","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.3390\/ijms23073441","volume":"23","author":"G Gerlini","year":"2022","unstructured":"G. Gerlini, P. Di Gennaro, N. Pimpinelli, S. Sestini, L. Borgognoni, Tolerogenic IDO1(+)CD83(-) langerhans cells in Sentinel Lymph nodes of patients with Melanoma. Int. J. Mol. Sci. 23(7), 3441 (2022)","journal-title":"Int. J. Mol. Sci."},{"key":"1027_CR62","doi-asserted-by":"publisher","first-page":"107964","DOI":"10.1016\/j.pharmthera.2021.107964","volume":"230","author":"Y Kanai","year":"2022","unstructured":"Y. Kanai, Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol. Ther. 230, 107964 (2022)","journal-title":"Pharmacol. Ther."},{"key":"1027_CR63","doi-asserted-by":"crossref","unstructured":"A. Shimizu, K. Kaira, M. Kato et al., Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma. Melanoma Res. 25(5), 399\u2013405 (2015)","DOI":"10.1097\/CMR.0000000000000181"},{"issue":"1","key":"1027_CR64","doi-asserted-by":"publisher","first-page":"13943","DOI":"10.1038\/s41598-023-41096-3","volume":"13","author":"Z Shi","year":"2023","unstructured":"Z. Shi, K. Kaneda-Nakashima, R. Ohgaki et al., Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models. Sci. Rep. 13(1), 13943 (2023)","journal-title":"Sci. Rep."},{"issue":"2","key":"1027_CR65","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/cas.14756","volume":"112","author":"H Okanishi","year":"2021","unstructured":"H. Okanishi, R. Ohgaki, S. Okuda, H. Endou, Y. Kanai, Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor. Cancer Sci. 112(2), 871\u2013883 (2021)","journal-title":"Cancer Sci."},{"key":"1027_CR66","doi-asserted-by":"crossref","unstructured":"L.L. Gonzalez, K. Garrie, M.D. Turner, Role of S100 proteins in health and disease. Biochim. Biophys. Acta Mol. Cell Res. 1867(6), 118677 (2020)","DOI":"10.1016\/j.bbamcr.2020.118677"},{"issue":"3","key":"1027_CR67","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/paor.1999.0218","volume":"5","author":"T B\u00e1nfalvi","year":"1999","unstructured":"T. B\u00e1nfalvi, K. Gilde, M. Boldizs\u00e1r, T. Kremmer, S. Ott\u00f3, Serum levels of S-100 protein and 5-S-cysteinyldopa as markers of melanoma progression. Pathol. Oncol. Res. 5(3), 218\u2013222 (1999)","journal-title":"Pathol. Oncol. Res."},{"issue":"6","key":"1027_CR68","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/00008390-200312000-00008","volume":"13","author":"K Stoitchkov","year":"2003","unstructured":"K. Stoitchkov, S. Letellier, J.P. Garnier et al., Evaluation of the serum L-dopa\/L-tyrosine ratio as a melanoma marker. Melanoma Res. 13(6), 587\u2013593 (2003)","journal-title":"Melanoma Res."},{"issue":"9","key":"1027_CR69","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","volume":"9","author":"RK Amaravadi","year":"2019","unstructured":"R.K. Amaravadi, A.C. Kimmelman, J. Debnath, Targeting Autophagy in Cancer: recent advances and future directions. Cancer Discov. 9(9), 1167\u20131181 (2019)","journal-title":"Cancer Discov"},{"issue":"8","key":"1027_CR70","doi-asserted-by":"publisher","first-page":"13262","DOI":"10.1002\/jcb.28600","volume":"120","author":"H Tang","year":"2019","unstructured":"H. Tang, X. Xu, W. Xiao et al., Silencing of microRNA-27a facilitates autophagy and apoptosis of melanoma cells through the activation of the SYK-dependent mTOR signaling pathway. J. Cell. Biochem. 120(8), 13262\u201313274 (2019)","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"1027_CR71","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.cell.2018.03.026","volume":"173","author":"SA Shukla","year":"2018","unstructured":"S.A. Shukla, P. Bachireddy, B. Schilling et al., Cancer-Germline Antigen expression discriminates clinical outcome to CTLA-4 blockade. Cell. 173(3), 624\u2013633e8 (2018)","journal-title":"Cell"},{"issue":"10","key":"1027_CR72","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1172\/JCI26390","volume":"115","author":"B Levine","year":"2005","unstructured":"B. Levine, J. Yuan, Autophagy in cell death: an innocent convict? J. Clin. Invest. 115(10), 2679\u20132688 (2005)","journal-title":"J. Clin. Invest."},{"issue":"5","key":"1027_CR73","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ccell.2018.04.007","volume":"33","author":"LV Kemeny","year":"2018","unstructured":"L.V. Kemeny, D.E. Fisher, Targeting the (Un)differentiated state of Cancer. Cancer Cell. 33(5), 793\u2013795 (2018)","journal-title":"Cancer Cell."},{"issue":"1","key":"1027_CR74","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/pcmr.13009","volume":"35","author":"R Talty","year":"2022","unstructured":"R. Talty, M. Bosenberg, The role of ferroptosis in melanoma. Pigment Cell. Melanoma Res. 35(1), 18\u201325 (2022)","journal-title":"Pigment Cell. Melanoma Res."},{"issue":"1","key":"1027_CR75","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1038\/s41598-022-09078-z","volume":"12","author":"M Nyakas","year":"2022","unstructured":"M. Nyakas, K.G. Fleten, M.H. Haugen et al., AXL inhibition improves BRAF-targeted treatment in melanoma. Sci. Rep. 12(1), 5076 (2022)","journal-title":"Sci. Rep."},{"issue":"12","key":"1027_CR76","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/jid.2011.218","volume":"131","author":"M Sensi","year":"2011","unstructured":"M. Sensi, M. Catani, G. Castellano et al., Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional axl receptor kinase. J. Invest. Dermatol. 131(12), 2448\u20132457 (2011)","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"1027_CR77","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/pcmr.12222","volume":"27","author":"H Stanisz","year":"2014","unstructured":"H. Stanisz, S. Saul, C.S. M\u00fcller et al., Inverse regulation of melanoma growth and migration by Orai1\/STIM2-dependent calcium entry. Pigment Cell. Melanoma Res. 27(3), 442\u2013453 (2014)","journal-title":"Pigment Cell. Melanoma Res."},{"issue":"10","key":"1027_CR78","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1046\/j.1365-2362.2000.00710.x","volume":"30","author":"T B\u00e1nfalvi","year":"2000","unstructured":"T. B\u00e1nfalvi, K. Gilde, M. Boldizs\u00e1r et al., Serum concentration of 5-S-cysteinyldopa in patients with melanoma. Eur. J. Clin. Invest. 30(10), 900\u2013904 (2000)","journal-title":"Eur. J. Clin. Invest."},{"key":"1027_CR79","doi-asserted-by":"crossref","unstructured":"J. Oba, W. Wei, J.E. Gershenwald et al., Elevated serum leptin levels are associated with an increased risk of Sentinel lymph node metastasis in cutaneous melanoma. Medicine (Baltimore). 95(11), e3073 (2016)","DOI":"10.1097\/MD.0000000000003073"},{"issue":"13","key":"1027_CR80","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-10-3787","volume":"71","author":"AS Lee","year":"2011","unstructured":"A.S. Lee, D.H. Kim, J.E. Lee et al., Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res. 71(13), 4506\u20134517 (2011)","journal-title":"Cancer Res."},{"issue":"7519","key":"1027_CR81","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"O.R. Colegio, N. Chu, A.L. Szabo et al., Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 513(7519), 559\u2013563 (2014)","journal-title":"Nature"},{"issue":"21","key":"1027_CR82","doi-asserted-by":"publisher","first-page":"8359","DOI":"10.3390\/ijms21218359","volume":"21","author":"A Simiczyjew","year":"2020","unstructured":"A. Simiczyjew, E. Dratkiewicz, J. Mazurkiewicz et al., The influence of Tumor Microenvironment on Immune escape of Melanoma. Int. J. Mol. Sci. 21(21), 8359 (2020)","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"1027_CR83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/cancers14010123","volume":"14","author":"OS Cherepakhin","year":"2022","unstructured":"O.S. Cherepakhin, Z.B. Argenyi, A.S. Moshiri, Genomic and Transcriptomic Underpinnings of Melanoma Genesis, Progression, and Metastasis. Cancers (Basel). 14(1), 123 (2022)","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1027_CR84","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.4049\/jimmunol.181.5.3291","volume":"181","author":"S Watanabe","year":"2008","unstructured":"S. Watanabe, K. Deguchi, R. Zheng et al., Tumor-Induced CD11b\u2009+\u2009Gr-1\u2009+\u2009myeloid cells suppress T cell sensitization in Tumor-Draining Lymph Nodes1. J. Immunol. 181(5), 3291\u20133300 (2008)","journal-title":"J. Immunol."},{"issue":"1","key":"1027_CR85","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41598-019-56542-4","volume":"10","author":"P Sharma","year":"2020","unstructured":"P. Sharma, B. Diergaarde, S. Ferrone, J.M. Kirkwood, T.L. Whiteside, Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells. Sci. Rep. 10(1), 92 (2020)","journal-title":"Sci. Rep."},{"issue":"12","key":"1027_CR86","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43018-021-00272-y","volume":"2","author":"S Garc\u00eda-Silva","year":"2021","unstructured":"S. Garc\u00eda-Silva, A. Benito-Mart\u00edn, L. Nogu\u00e9s et al., Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. Nat. Cancer. 2(12), 1387\u20131405 (2021)","journal-title":"Nat. Cancer"},{"issue":"9","key":"1027_CR87","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jid.2023.02.030","volume":"143","author":"GS Leichner","year":"2023","unstructured":"G.S. Leichner, I. Schweitzer, S. Dror et al., Primary Melanoma miRNA trafficking induces Lymphangiogenesis. J. Invest. Dermatol. 143(9), 1788\u20131798e7 (2023)","journal-title":"J. Invest. Dermatol."},{"key":"1027_CR88","doi-asserted-by":"crossref","unstructured":"R. Singh, B.K. Choi, Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis. Elife 8, e48916 (2019)","DOI":"10.7554\/eLife.48916"},{"issue":"12","key":"1027_CR89","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1158\/2326-6066.CIR-22-0225","volume":"10","author":"T Virgilio","year":"2022","unstructured":"T. Virgilio, J. Bordini, L. Cascione et al., Subcapsular sinus macrophages promote Melanoma Metastasis to the Sentinel Lymph nodes via an IL1\u03b1\u2013STAT3 Axis. Cancer Immunol. Res. 10(12), 1525\u20131541 (2022)","journal-title":"Cancer Immunol. Res."},{"key":"1027_CR90","doi-asserted-by":"publisher","first-page":"215841","DOI":"10.1016\/j.canlet.2022.215841","volume":"545","author":"Z Du","year":"2022","unstructured":"Z. Du, Y. Feng, H. Zhang, J. Liu, J. Wang, Melanoma-derived small extracellular vesicles remodel the systemic onco-immunity via disrupting hematopoietic stem cell proliferation and differentiation. Cancer Lett. 545, 215841 (2022)","journal-title":"Cancer Lett."},{"issue":"MAR","key":"1027_CR91","first-page":"358","volume":"8","author":"R Maus","year":"2017","unstructured":"R. Maus, J.W. Jakub, W.K. Nevala et al., Human melanoma-derived extracellular vesicles regulate dendritic cell maturation. Front. Immunol. 8(MAR), 358 (2017)","journal-title":"Front. Immunol."},{"key":"1027_CR92","doi-asserted-by":"crossref","unstructured":"M. Feiya, V. Jensen, L. Grace, W. Yuqi, P. Guangyong, Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment. J. Immunother. Cancer 9(10), e003217 (2021)","DOI":"10.1136\/jitc-2021-003217"},{"key":"1027_CR93","doi-asserted-by":"crossref","unstructured":"W. Wagstaff, R.N. Mwamba, K. Grullon et al., Melanoma: molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance. Genes Dis. 9(6), 1608\u20131623 (2022)","DOI":"10.1016\/j.gendis.2022.04.004"},{"key":"1027_CR94","doi-asserted-by":"publisher","first-page":"909580","DOI":"10.3389\/fimmu.2022.909580","volume":"13","author":"N Sun","year":"2022","unstructured":"N. Sun, Y. Tian, Y. Chen, W. Guo, C. Li, Metabolic rewiring directs melanoma immunology. Front. Immunol. 13, 909580 (2022)","journal-title":"Front. Immunol."},{"issue":"9","key":"1027_CR95","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"K. Fischer, P. Hoffmann, S. Voelkl et al., Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells. Blood. 109(9), 3812\u20133819 (2007)","journal-title":"Blood"},{"issue":"5","key":"1027_CR96","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"A. Brand, K. Singer, G.E. Koehl et al., LDHA-Associated Lactic Acid Production blunts Tumor Immunosurveillance by T and NK Cells. Cell. Metab. 24(5), 657\u2013671 (2016)","journal-title":"Cell. Metab."},{"issue":"10","key":"1027_CR97","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.humpath.2007.02.018","volume":"38","author":"D Massi","year":"2007","unstructured":"D. Massi, C. Marconi, A. Franchi et al., Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. Hum. Pathol. 38(10), 1516\u20131525 (2007)","journal-title":"Hum. Pathol."},{"issue":"6402","key":"1027_CR98","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/360355a0","volume":"360","author":"M Auvinen","year":"1992","unstructured":"M. Auvinen, A. Paasinen, L.C. Andersson, E. H\u00f6ltt\u00e4, Ornithine decarboxylase activity is critical for cell transformation. Nature. 360(6402), 355\u2013358 (1992)","journal-title":"Nature"},{"issue":"13","key":"1027_CR99","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1016\/j.celrep.2018.12.002","volume":"25","author":"CD Commerford","year":"2018","unstructured":"C.D. Commerford, L.C. Dieterich, Y. He et al., Mechanisms of Tumor-Induced Lymphovascular Niche formation in draining Lymph Nodes. Cell. Rep. 25(13), 3554\u20133563e4 (2018)","journal-title":"Cell. Rep."},{"key":"1027_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2017.12.013","volume":"174","author":"T Liberato","year":"2018","unstructured":"T. Liberato, D.S. Pessotti, I. Fukushima et al., Signatures of protein expression revealed by secretome analyses of cancer associated fibroblasts and melanoma cell lines. J. Proteom. 174, 1\u20138 (2018)","journal-title":"J. Proteom."},{"issue":"4","key":"1027_CR101","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41590-020-0635-3","volume":"21","author":"AT Krishnamurty","year":"2020","unstructured":"A.T. Krishnamurty, S.J. Turley, Lymph node stromal cells: cartographers of the immune system. Nat. Immunol. 21(4), 369\u2013380 (2020)","journal-title":"Nat. Immunol."},{"issue":"2","key":"1027_CR102","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.immuni.2008.12.014","volume":"30","author":"R Roozendaal","year":"2009","unstructured":"R. Roozendaal, T.R. Mempel, L.A. Pitcher et al., Conduits mediate transport of low-molecular-weight Antigen to Lymph Node Follicles. Immunity. 30(2), 264\u2013276 (2009)","journal-title":"Immunity"},{"issue":"3","key":"1027_CR103","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/cells10030627","volume":"10","author":"H Zhou","year":"2021","unstructured":"H. Zhou, P. Lei, T.P. Padera, Progression of Metastasis through Lymphatic System. Cells. 10(3), 627 (2021)","journal-title":"Cells"},{"key":"1027_CR104","doi-asserted-by":"crossref","unstructured":"S.M. Soudja, S. Henri, M. Mello et al., Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells. PLoS One 6(7), e22639 (2011)","DOI":"10.1371\/journal.pone.0022639"},{"key":"1027_CR105","doi-asserted-by":"crossref","unstructured":"R. Adams, B. Moser, S.N. Karagiannis, K.E. Lacy, Chemokine pathways in cutaneous melanoma: their modulation by cancer and exploitation by the clinician. Cancers (Basel) 13(22), 5625 (2021)","DOI":"10.3390\/cancers13225625"},{"issue":"21","key":"1027_CR106","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/sj.onc.1210114","volume":"26","author":"JD Shields","year":"2007","unstructured":"J.D. Shields, M.S. Emmett, D.B. Dunn et al., Chemokine-mediated migration of melanoma cells towards lymphatics\u2013a mechanism contributing to metastasis. Oncogene. 26(21), 2997\u20133005 (2007)","journal-title":"Oncogene"},{"issue":"3","key":"1027_CR107","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1549-8719.2010.00074.x","volume":"18","author":"MS Emmett","year":"2011","unstructured":"M.S. Emmett, S. Lanati, D.B. Dunn, O.A. Stone, D.O. Bates, CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation. 18(3), 172\u2013182 (2011)","journal-title":"Microcirculation"},{"issue":"3","key":"1027_CR108","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.bjc.6606056","volume":"104","author":"S Amatschek","year":"2011","unstructured":"S. Amatschek, R. Lucas, A. Eger et al., CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. Br. J. Cancer. 104(3), 469\u2013479 (2011)","journal-title":"Br. J. Cancer"},{"issue":"2","key":"1027_CR109","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/bjc.2015.193","volume":"113","author":"SC Wightman","year":"2015","unstructured":"S.C. Wightman, A. Uppal, S.P. Pitroda et al., Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br. J. Cancer. 113(2), 327\u2013335 (2015)","journal-title":"Br. J. Cancer"},{"key":"1027_CR110","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2147\/OTT.S157421","volume":"11","author":"Y Zhang","year":"2018","unstructured":"Y. Zhang, L. Xu, M. Peng, CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis. Onco Targets Ther. 11, 1045\u20131054 (2018)","journal-title":"Onco Targets Ther."},{"issue":"8","key":"1027_CR111","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00262-017-1988-9","volume":"66","author":"V Umansky","year":"2017","unstructured":"V. Umansky, C. Blattner, C. Gebhardt, J. Utikal, CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma. Cancer Immunol. Immunother. 66(8), 1015\u20131023 (2017)","journal-title":"Cancer Immunol. Immunother"},{"key":"1027_CR112","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3389\/fimmu.2020.01680","volume":"11","author":"P De Cicco","year":"2020","unstructured":"P. De Cicco, G. Ercolano, A. Ianaro, The New Era of Cancer Immunotherapy: targeting myeloid-derived suppressor cells to overcome Immune Evasion. Front. Immunol. 11, 1680 (2020)","journal-title":"Front. Immunol."},{"issue":"4","key":"1027_CR113","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/path.5207","volume":"247","author":"J Liu","year":"2019","unstructured":"J. Liu, C. Wang, X. Ma et al., High expression of CCR5 in melanoma enhances epithelial-mesenchymal transition and metastasis via TGF\u03b21. J. Pathol. 247(4), 481\u2013493 (2019)","journal-title":"J. Pathol."},{"key":"1027_CR114","doi-asserted-by":"crossref","unstructured":"B. Toh, X. Wang, J. Keeble et al., Mesenchymal transition and dissemination of Cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol. 9(9), e1001162 (2011)","DOI":"10.1371\/journal.pbio.1001162"},{"issue":"7","key":"1027_CR115","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/ijc.32278","volume":"145","author":"Z Li","year":"2019","unstructured":"Z. Li, J. Zhou, J. Zhang et al., Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. Int. J. Cancer. 145(7), 1946\u20131957 (2019)","journal-title":"Int. J. Cancer"},{"issue":"7","key":"1027_CR116","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.jid.2018.01.035","volume":"138","author":"A Soler-Cardona","year":"2018","unstructured":"A. Soler-Cardona, A. Forsthuber, K. Lipp et al., CXCL5 facilitates Melanoma Cell\u2013Neutrophil Interaction and Lymph Node Metastasis. J. Invest. Dermatol. 138(7), 1627\u20131635 (2018)","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"1027_CR117","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nm0202-157","volume":"8","author":"B Homey","year":"2002","unstructured":"B. Homey, H. Alenius, A. M\u00fcller et al., CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8(2), 157\u2013165 (2002)","journal-title":"Nat. Med."},{"issue":"13","key":"1027_CR118","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41388-021-01683-y","volume":"40","author":"V Rawat","year":"2021","unstructured":"V. Rawat, P. Malvi, D. Della Manna et al., PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. Oncogene. 40(13), 2448\u20132462 (2021)","journal-title":"Oncogene"},{"key":"1027_CR119","doi-asserted-by":"publisher","first-page":"100874","DOI":"10.1016\/j.neo.2022.100874","volume":"36","author":"A Mehdi","year":"2023","unstructured":"A. Mehdi, M. Attias, A. Arakelian et al., S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas. Neoplasia. 36, 100874 (2023)","journal-title":"Neoplasia"},{"issue":"1","key":"1027_CR120","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1038\/s41467-023-38968-7","volume":"14","author":"J Liang","year":"2023","unstructured":"J. Liang, D. Yu, C. Luo et al., Epigenetic suppression of PGC1\u03b1 (PPARGC1A) causes collateral sensitivity to HMGCR-inhibitors within BRAF-treatment resistant melanomas. Nat. Commun. 14(1), 3251 (2023)","journal-title":"Nat. Commun."},{"issue":"11","key":"1027_CR121","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00018-023-04965-8","volume":"80","author":"Y Tian","year":"2023","unstructured":"Y. Tian, J. Ma, H. Wang et al., BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions. Cell. Mol. Life Sci. 80(11), 315 (2023)","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-01027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-024-01027-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-01027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:19:28Z","timestamp":1736284768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-024-01027-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":121,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1027"],"URL":"https:\/\/doi.org\/10.1007\/s13402-024-01027-4","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"8 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}